Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China

BACKGROUND: Lipid-lowering therapy (LLT) is one of the key strategies for reducing the atherosclerotic cardiovascular disease (ASCVD) burden. However, little is known about the percentage of people in need of different LLT regimens to achieve optimal targets of low-density lipoprotein cholesterol (L...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Lei, Yi, Jiayi, Wu, Chaoqun, Hu, Shuang, Zhang, Xingyi, Lu, Jiapeng, Liu, Jiamin, Zhang, Haibo, Yang, Yang, Cui, Jianlan, Xu, Wei, Song, Lijuan, Guo, Yuanlin, Li, Xi, Zheng, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996051/
https://www.ncbi.nlm.nih.gov/pubmed/35419429
http://dx.doi.org/10.3389/fcvm.2022.839571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996051/
https://www.ncbi.nlm.nih.gov/pubmed/35419429
http://dx.doi.org/10.3389/fcvm.2022.839571

Ejemplares similares